catalent novo holdings news - Search News

Catalent, Novo Holdings

FiercePharma · 5h

Novo Holdings set to close $16.5B Catalent buy in 'coming days' after deal clears antitrust hurdles

After clearing all regulatory hurdles associated with its proposed buyout of CDMO Catalent, Novo Holdings is nearly ready to unwrap its $16.5 billion present just in time for the holidays.

Pharmalittle: We’re reading about Novo Holdings proceeding with Catalent deal, Sanofi threatened with sanctions, and more

Novo Holdings can proceed with its planned $16.5 billion acquisition of Catalent after U.S. regulators declined to challenge the deal

Reuters on MSN · 2d

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say

All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent had been fulfilled, the companies said on Saturday, adding that the transaction is expected to be completed in the coming days.

YAHOO!Finance · 10h

Novo Holdings’ purchase of Catalent set to close after regulators’ green light

The $16.5 billion take-private deal can now be completed, and along with it Novo Nordisk’s related acquisition of three Catalent drug manufacturing plants.

Indiana Daily Student · 2d

Novo’s takeover of Catalent set to proceed after FTC declines to challenge deal

Novo Holdings will proceed with its $16.5 billion acquisition of Catalent, the companies announced Saturday, after the Federal Trade Commission decided not to challenge the deal. It’s expected to close in the coming days.

Seeking Alpha on MSN · 2d

Novo Nordisk says Catalent buyout to close soon as regulatory conditions met

Novo Nordisk (NVO) announced Saturday that its pending acquisition of three Catalent (NYSE:CTLT) production sites is expected to close within days as its parent entity satisfied all regulatory conditions to buy the U.

Business Insider · 1d

Catalent And Novo Holdings Complete All Regulatory Closing Conditions For Merger

Catalent Inc. (CTLT) and Novo Holdings A/S announced that the companies have fulfilled all regulatory closing conditions for their

Bloomberg on MSN · 2d

Novo Nordisk Set to Close Catalent Deal Without FTC Challenge

Novo Nordisk A/S can advance with its acquisition of factories from contract development and manufacturing organization Catalent Inc. after the Federal Trade Commission declined to challenge the deal.

Denmark, Novo Nordisk

YAHOO!Finance · 7h

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent

Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) announced plans to invest approximately $1.20 billion (8.5 billion Danish kroner) to establish a new production facility in Odense, Denmark. The investment marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new production site.

Novo Deepens Denmark Commitment With $1.2B Rare Disease Production Facility

Novo’s latest investment comes just days after the U.S. FTC greenlit the highly contentious acquisition of Catalent, which analysts expect will help the pharma expand its production capacity.

Wall Street Journal · 13h

Novo Nordisk to Invest $1.2 Bln in New Production Facility in Denmark

The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the rare disease area, such as haemophilia.

Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle

Novo Holdings is on track to acquire Catalent, a global contract development and manufacturing organization, in a $16.5 ...

Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition

Now that they’ve received the go-signal from both U.S. and EU anti-trust regulators, Novo Holdings and Catalent expect to ...

Indiana Daily Student11d

What Novo’s takeover of Catalent could mean for Bloomington workers

Years of layoffs and alleged mismanagement have left employees “sick” of the pharmaceutical contract manufacturer Catalent, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results